Skip to main content
NCBI home page
Mediators of Inflammation logoLink to Mediators of Inflammation
. 1997 Feb;6(1):75–77. doi: 10.1080/09629359791983

Eicosanoid and cytokine levels in plasma of patients during mesenteric infarction

N Nathan 1,✉, Y Denizot 2, P Feiss 1
PMCID: PMC2365838  PMID: 18472839

Abstract

Multible organ failure (MOF) induced by mesenteric infarction is associated with a high mortality rate. This study reports eicosanoid and cytokine levels in the blood of three atherosclerotic patients who ultimately died from MOF induced by mesenteric infarction. High plasma levels of 6- keto-prostaglandin (PG) F1α (the stable metabolite of PGI2), interleukin (IL)-6 and IL-8 are observed whereas plasma tumour necrosis factor alpha (TNFα), TxB2 (the stable metabolite of TxA2), PGE2, leukotrienes (LT)B4 and LTC4, and whole blood platelet-activating factor levels are not different from values obtained in similarly severe atherosclerotic patients. This short report questioned the clinical involvement of TNFα during such a pathology where a persistent translocation of endotoxin has been observed through the gut endothelial barrier. Activation of phospholipase A2 is suggested by the increase in the stable metabolite of PGI2 and might be by itself or through lipidic metabolites, a major systemic stimulus of IL-6 and IL-8 production.

Full Text

The Full Text of this article is available as a PDF (120.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Denizot Y., Trimoreau F., Dupuis F., Verger C., Praloran V. PAF and haematopoiesis: III. Presence and metabolism of platelet-activating factor in human bone marrow. Biochim Biophys Acta. 1995 Feb 16;1265(1):55–60. doi: 10.1016/0167-4889(94)00193-i. [DOI] [PubMed] [Google Scholar]
  2. Filep J. G., Braquet P., Mózes T. Interactions between platelet-activating factor and prostanoids during mesenteric ischemia-reperfusion-induced shock in the anesthetized dog. Circ Shock. 1991 Sep;35(1):1–8. [PubMed] [Google Scholar]
  3. Gögler H., Meckes P., Beger H. G. Endotoxin bei diffus-eitriger Peritonitis. Zentralbl Chir. 1985;110(22):1388–1398. [PubMed] [Google Scholar]
  4. Koike K., Moore E. E., Moore F. A., Kim F. J., Carl V. S., Banerjee A. Gut phospholipase A2 mediates neutrophil priming and lung injury after mesenteric ischemia-reperfusion. Am J Physiol. 1995 Mar;268(3 Pt 1):G397–G403. doi: 10.1152/ajpgi.1995.268.3.G397. [DOI] [PubMed] [Google Scholar]
  5. Koike K., Moore E. E., Moore F. A., Read R. A., Carl V. S., Banerjee A. Gut ischemia/reperfusion produces lung injury independent of endotoxin. Crit Care Med. 1994 Sep;22(9):1438–1444. doi: 10.1097/00003246-199409000-00014. [DOI] [PubMed] [Google Scholar]
  6. Miwa M., Miyake T., Yamanaka T., Sugatani J., Suzuki Y., Sakata S., Araki Y., Matsumoto M. Characterization of serum platelet-activating factor (PAF) acetylhydrolase. Correlation between deficiency of serum PAF acetylhydrolase and respiratory symptoms in asthmatic children. J Clin Invest. 1988 Dec;82(6):1983–1991. doi: 10.1172/JCI113818. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Mediators of Inflammation are provided here courtesy of Wiley

RESOURCES